Healthcare provider profile · identity verified

David Willis Mcmurry, MD

Internal Medicine · CONCORD, NC · NPI 1114999539

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1307	338
Omeprazole	Omeprazole	913	238
Amlodipine Besylate	Amlodipine Besylate	896	222
Losartan Potassium	Losartan Potassium	635	174
Levothyroxine Sodium	Levothyroxine Sodium	535	130
Metoprolol Succinate	Metoprolol Succinate	443	118
Alprazolam	Alprazolam	374	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	350	58
Lisinopril	Lisinopril	339	87
Furosemide	Furosemide	332	96
Gabapentin	Gabapentin	287	75
Tamsulosin Hcl	Tamsulosin Hcl	279	78
Pravastatin Sodium	Pravastatin Sodium	278	61
Metformin Hcl Er	Metformin Hcl	276	79
Metoprolol Tartrate	Metoprolol Tartrate	265	67
Tramadol Hcl	Tramadol Hcl	265	61
Eliquis	Apixaban	260	50
Rosuvastatin Calcium	Rosuvastatin Calcium	254	75
Zolpidem Tartrate	Zolpidem Tartrate	249	42
Metformin Hcl	Metformin Hcl	243	67
Potassium Chloride	Potassium Chloride	217	60
Fluticasone Propionate	Fluticasone Propionate	193	63
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	184	45
Prednisone	Prednisone	176	117
Glipizide	Glipizide	166	48
Olmesartan Medoxomil	Olmesartan Medoxomil	165	50
Citalopram Hbr	Citalopram Hydrobromide	159	37
Clopidogrel	Clopidogrel Bisulfate	154	33
Pantoprazole Sodium	Pantoprazole Sodium	153	37
Meloxicam	Meloxicam	152	39
Simvastatin	Simvastatin	151	39
Escitalopram Oxalate	Escitalopram Oxalate	149	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	147	37
Montelukast Sodium	Montelukast Sodium	146	39
Lorazepam	Lorazepam	145	28
Hydrochlorothiazide	Hydrochlorothiazide	141	38
Alendronate Sodium	Alendronate Sodium	125	26
Valsartan	Valsartan	125	34
Allopurinol	Allopurinol	123	34
Albuterol Sulfate Hfa	Albuterol Sulfate	122	48
Trazodone Hcl	Trazodone Hcl	119	28
Celecoxib	Celecoxib	118	32
Pioglitazone Hcl	Pioglitazone Hcl	113	27
Sertraline Hcl	Sertraline Hcl	113	35
Carvedilol	Carvedilol	110	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	28
Fluoxetine Hcl	Fluoxetine Hcl	104	27
Clonazepam	Clonazepam	101	14
Trulicity	Dulaglutide	101	13
Finasteride	Finasteride	89	23
Buspirone Hcl	Buspirone Hcl	85	18
Duloxetine Hcl	Duloxetine Hcl	84	24
Esomeprazole Magnesium	Esomeprazole Magnesium	79	17
Famotidine	Famotidine	78	21
Bupropion Xl	Bupropion Hcl	75	18
Fenofibrate	Fenofibrate	74	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	16
Mirtazapine	Mirtazapine	74	17
Atenolol	Atenolol	65	12
Warfarin Sodium	Warfarin Sodium	65	17
Glipizide Er	Glipizide	64	19
Quetiapine Fumarate	Quetiapine Fumarate	62	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	61	14
Triamcinolone Acetonide	Triamcinolone Acetonide	61	39
Ezetimibe	Ezetimibe	58	11
Ozempic	Semaglutide	57	11
Ipratropium Bromide	Ipratropium Bromide	55	14
Hydralazine Hcl	Hydralazine Hcl	54	14
Lovastatin	Lovastatin	54	13
Azithromycin	Azithromycin	50	47
Venlafaxine Hcl Er	Venlafaxine Hcl	49	15
Diclofenac Sodium	Diclofenac Sodium	48	11
Diazepam	Diazepam	47	suppressed
Estradiol	Estradiol	43	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	43	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	12
Pregabalin	Pregabalin	41	suppressed
Spironolactone	Spironolactone	39	12
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Glimepiride	Glimepiride	37	suppressed
Baclofen	Baclofen	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Azelastine Hcl	Azelastine Hcl	34	16
Irbesartan	Irbesartan	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	31
Januvia	Sitagliptin Phosphate	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Temazepam	Temazepam	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	30	suppressed
Amoxicillin	Amoxicillin	29	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Fenofibrate	Fenofibrate,micronized	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Methylprednisolone	Methylprednisolone	25	24
Myrbetriq	Mirabegron	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Linzess	Linaclotide	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	12
Ondansetron Hcl	Ondansetron Hcl	20	14
Topiramate	Topiramate	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Telmisartan	Telmisartan	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Nitroglycerin	Nitroglycerin	18	15
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Tiadylt Er	Diltiazem Hcl	17	suppressed
Primidone	Primidone	16	suppressed
Risperidone	Risperidone	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Cephalexin	Cephalexin	15	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Levofloxacin	Levofloxacin	14	13
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Desipramine Hcl	Desipramine Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Colchicine	Colchicine	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error